From FDA and Health Canada approvals to joint ventures, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Joimax Endovapor 2 Joimax announced in an April 26 press release that it has received FDA 510(k) clearance to market its Endovapor 2 Multi-Radio Frequency System. The device […]
FDA warns Eclipse Aesthetics on MicroPen personal dermabrasion device
The FDA recently released a warning letter it sent to Eclipse Aesthetics, claiming the company lacks appropriate regulatory clearance for its Eclipse Micropen Elite, which it describes as a “dermal micro-needling device” used for skincare applications. The letter came after an FDA inspection in August last year uncovered that the Eclipse MicroPen Elite did not […]
EnteroMedics names ex-Lanx chief Gladney as CEO | Personnel Moves
EnteroMedics (NSDQ:ETRM) said it named Dan Gladney, the former chief executive who led Lanx to an acquisition by Biomet, to be its new CEO effective Nov. 16. St. Paul, Minn.-based EnteroMedics said chairman, president & CEO Mark Knudson will become executive chairman when Gladney takes over the corner office until Jan. 1, 2016, when he will […]
Syneron settles patent lawsuit against EndyMed
Syneron Medical (NSDQ:ELOS) dropped a patent infringement lawsuit against EndyMed Medical and its distributor, Eclipse Aesthetics, after EndyMed agreed to stop selling its fractional skin resurfacing products in the U.S.
EndyMed will continue to re-supply electrodes and other maintenance items for the products it has already sold, according to a press release.
Syneron sues aesthetics duo over skin-tightening technology
Israel-based maker Syneron Medical (NSDQ:ELOS) sued a pair of rival companies over devices that allegedly infringe on 2 Syneron patents for skin ablation technology.
Syneron claimed that EndyMed Medical and Eclipse Aesthetics infringe on the patents by selling use electrodes to apply ablative energy to the skin.
MassDevice Network
@MassDevice
LinkedIn
YouTube